Toxikon and Ocean Ridge Biosciences (ORB), a genomic services provider to the life science industry, have formed a partnership to globally market their respective expertise and provide increased discovery through preclinical development services to its clients.   The two companies began their partnership with the development of an ocular disease model, assessing and validating target cytokine levels in inflamed versus healthy animal tissue. The lipopolysaccharides (LPS) injection-based uveit...